These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 30503134)

  • 41. Fertility preservation options in breast cancer patients.
    Kasum M; von Wolff M; Franulić D; Čehić E; Klepac-Pulanić T; Orešković S; Juras J
    Gynecol Endocrinol; 2015; 31(11):846-51. PubMed ID: 26370157
    [TBL] [Abstract][Full Text] [Related]  

  • 42. BRCA mutation carriers show normal ovarian response in in vitro fertilization cycles.
    Shapira M; Raanani H; Feldman B; Srebnik N; Dereck-Haim S; Manela D; Brenghausen M; Geva-Lerner L; Friedman E; Levi-Lahad E; Goldberg D; Perri T; Eldar-Geva T; Meirow D
    Fertil Steril; 2015 Nov; 104(5):1162-7. PubMed ID: 26335130
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Double ovarian stimulation (DuoStim) protocol for fertility preservation in female oncology patients.
    Tsampras N; Gould D; Fitzgerald CT
    Hum Fertil (Camb); 2017 Dec; 20(4):248-253. PubMed ID: 28423955
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of salpingectomy on ovarian response to hyperstimulation during in vitro fertilization: a meta-analysis.
    Fan M; Ma L
    Fertil Steril; 2016 Aug; 106(2):322-329.e9. PubMed ID: 27114330
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fertility preservation using controlled ovarian hyperstimulation and oocyte cryopreservation in a premenarcheal female with myelodysplastic syndrome.
    Reichman DE; Davis OK; Zaninovic N; Rosenwaks Z; Goldschlag DE
    Fertil Steril; 2012 Nov; 98(5):1225-8. PubMed ID: 22884018
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy of random-start controlled ovarian stimulation in cancer patients.
    Kim JH; Kim SK; Lee HJ; Lee JR; Jee BC; Suh CS; Kim SH
    J Korean Med Sci; 2015 Mar; 30(3):290-5. PubMed ID: 25729252
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of letrozole or tamoxifen coadministered with a standard stimulation protocol on fertility preservation among breast cancer patients.
    Shulman Y; Almog B; Kalma Y; Fouks Y; Azem F; Cohen Y
    J Assist Reprod Genet; 2021 Mar; 38(3):743-750. PubMed ID: 33409757
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ovarian stimulation for oocyte cryopreservation for prevention of age-related fertility loss: one in five is a low responder.
    Tsafrir A; Haimov-Kochman R; Margalioth EJ; Eldar-Geva T; Gal M; Bdolah Y; Imbar T; Hurwitz A; Ben-Chetrit A; Goldberg D
    Gynecol Endocrinol; 2015 Oct; 31(10):779-82. PubMed ID: 26291805
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Progesterone levels in letrozole associated controlled ovarian stimulation for fertility preservation in breast cancer patients.
    Goldrat O; Gervy C; Englert Y; Delbaere A; Demeestere I
    Hum Reprod; 2015 Sep; 30(9):2184-9. PubMed ID: 26109617
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Live birth using vitrified--warmed oocytes in invasive ovarian cancer: case report and literature review.
    Alvarez M; Solé M; Devesa M; Fábregas R; Boada M; Tur R; Coroleu B; Veiga A; Barri PN
    Reprod Biomed Online; 2014 Jun; 28(6):663-8. PubMed ID: 24745835
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Female fertility preservation: Impact of cancer on ovarian function and oocyte quality.
    Fabiani C; Ferrante MG; Meneghini C; Licata E; Paciotti G; Gallo M; Schiavi M; Spina V; Guarino A; Caserta D; Rago R
    Int J Gynaecol Obstet; 2022 Jan; 156(1):166-171. PubMed ID: 33837528
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impact of extent and biochemical parameters of lymphoma on fertility preservation outcome.
    Volodarsky-Perel A; Tulandi T; Son WY; Khojah M; Buckett W
    Fertil Steril; 2020 Feb; 113(2):400-407.e1. PubMed ID: 32106993
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vitro maturation of germinal vesicle oocytes recovered after premature luteinizing hormone surge: description of a novel approach to fertility preservation.
    Oktay K; Demirtas E; Son WY; Lostritto K; Chian RC; Tan SL
    Fertil Steril; 2008 Jan; 89(1):228.e19-22. PubMed ID: 17517403
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Systematic proposal of fertility preservation by mature oocyte cryopreservation for recurrent benign ovarian tumors].
    Dadoun Y; Azaïs H; Keller L; d'Orazio E; Collinet P; Decanter C
    Gynecol Obstet Fertil Senol; 2017 Jun; 45(6):359-365. PubMed ID: 28506797
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Thirteen years' experience in fertility preservation for cancer patients after in vitro fertilization and in vitro maturation treatments.
    Creux H; Monnier P; Son WY; Buckett W
    J Assist Reprod Genet; 2018 Apr; 35(4):583-592. PubMed ID: 29502188
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ovarian Stimulation in Patients With Cancer: Impact of Letrozole and BRCA Mutations on Fertility Preservation Cycle Outcomes.
    Turan V; Bedoschi G; Emirdar V; Moy F; Oktay K
    Reprod Sci; 2018 Jan; 25(1):26-32. PubMed ID: 28874104
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cumulative live birth rates after one ART cycle including all subsequent frozen-thaw cycles in 1050 women: secondary outcome of an RCT comparing GnRH-antagonist and GnRH-agonist protocols.
    Toftager M; Bogstad J; Løssl K; Prætorius L; Zedeler A; Bryndorf T; Nilas L; Pinborg A
    Hum Reprod; 2017 Mar; 32(3):556-567. PubMed ID: 28130435
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dual trigger with gonadotropin-releasing hormone agonist and standard dose human chorionic gonadotropin to improve oocyte maturity rates.
    Griffin D; Feinn R; Engmann L; Nulsen J; Budinetz T; Benadiva C
    Fertil Steril; 2014 Aug; 102(2):405-9. PubMed ID: 24842671
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Does type of cancer affect ovarian response in oncofertility patients?
    Hussein RS; Zhao Y; Khan Z
    J Gynecol Obstet Hum Reprod; 2021 Jun; 50(6):101944. PubMed ID: 33069914
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dual trigger for final oocyte maturation improves the oocyte retrieval rate of suboptimal responders to gonadotropin-releasing hormone agonist.
    Lu X; Hong Q; Sun L; Chen Q; Fu Y; Ai A; Lyu Q; Kuang Y
    Fertil Steril; 2016 Nov; 106(6):1356-1362. PubMed ID: 27490046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.